From a $10 billion bioeconomy to over $190 billion, indigenous CAR-T therapy, and a booming startup ecosystem highlight 12 years of transformation in India’s science and technology landscape
The country’s strength lies not just in technology availability but in adoption behaviour
At IIT Roorkee’s Vision 2047 conference, the union minister highlights BioE3 policy, rising biotech startups, and major scientific milestones
DBT-BIRAC, BioE3 and the Rs 10,000-crore Biopharma SHAKTI scheme aim to accelerate innovation, biomanufacturing and exports
Biotech potential of Himalayan territories including Jammu & Kashmir, particularly their agri-biotech potential remains still under-explored
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
Sirius JV will be owned 51% by Sirius and 49% by Adani
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
